Meditation may soothe chemo side effects, study finds
NCT ID NCT07470619
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a specific meditation technique, Twin Hearts Meditation, could reduce nausea and vomiting caused by chemotherapy in women with breast cancer. 102 women were split into two groups: one practiced meditation for 30 minutes at least three times a week, while the other received standard care. Researchers tracked nausea severity and vomiting episodes over 24 hours after chemotherapy to see if meditation made a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Twin Hearts Meditation (a guided relaxation technique)
- What this could lead to
- If it works, this could give women with breast cancer a simple, non-drug tool to reduce nausea and vomiting during chemotherapy, improving their quality of life.
- What could go wrong
- This is a small, completed trial with 102 participants. The meditation may not work for everyone, and results might not apply to other cancers or chemotherapy types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
102 people
The number who actually took part.
- Started
-
Jun 2016
- Finished
-
Jun 2016
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Women aged 18-65 years diagnosed with non-metastatic breast cancer. 2. Patients undergoing chemotherapy using standard chemotherapy regimens in the oncology unit. 3. Patients who had experienced nausea during at least one previous chemotherapy session. 4. Patients who voluntarily agreed to participate in the study and provided written informed consent Exclusion Criteria: 1. Performing meditation fewer than three times per week during the intervention period. 2. Unwillingness to continue participation in the study. 3. Presence of medical conditions that may independently cause nausea, such as severe gastrointestinal disease, renal failure, or hepatic disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Study site
Nicosia, KKTC (Turkish Republic of Northern Cyprus), 99138, Cyprus
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?